MICA and cervical carcinoma: For instance, in vitro experiments on cervical cancer displayed that the use of vorinostat (a histone deacetylase inhibitor) facilitates an increase in MICA expression, thereby enhancing NK cell toxicity against cervical cancer cells [28].